Affiliations 

  • 1 Department of Urology and Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
  • 2 Department of Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai, China
  • 3 Department of Urology, Xinchang County Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang, China
  • 4 Department of Urology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China
  • 5 Department of Urology, Xiangya Hospital Central South University, Changsha, Hunan, China
  • 6 Urology Unit, Department of Surgery, University Malaya Medical Centre, Kuala Lumpur, Malaysia
  • 7 Department of Urology, Prof. Dr. Ilhan Varank Research and Training Hospital, Istanbul, Turkey
  • 8 Department of Urology, Jose R. Reyes Memorial Medical Center, Manila, Philippines
  • 9 Institute of Urology, University College Hospitals of London, London, United Kingdom
  • 10 Department of Urology, National University Hospital, Singapore
EClinicalMedicine, 2024 Aug;74:102724.
PMID: 39070176 DOI: 10.1016/j.eclinm.2024.102724

Abstract

BACKGROUND: Retrograde intrarenal surgery (RIRS) is the main treatments for upper urinary tract stones. The Ureteral Access Sheath (UAS) serves as a supplementary tool, facilitating direct kidney access during RIRS. High quality of evidence comparing tip bendable suction ureteral access sheath (S-UAS) with traditional UAS in RIRS for the treatment of renal and ureteral stones is lacking. The purpose of the study is to compare the efficacy and safety of S-UAS with traditional UAS in RIRS for the treatment of renal or ureteral stones ≤30 mm.

METHODS: An international, multicenter, and superiority randomized controlled trial included 320 intention-to-treat patients across 8 medical centers in China, the Philippines, Malaysia and Turkey from August 2023 to February 2024. The inclusion criteria were patients ≥18 years old with renal or ureteral stones ≤30 mm. RIRS was performed using either S-UAS or traditional UAS. The primary outcome was the immediately stone-free rate (SFR). Secondary outcomes included SFR 3 months after operation, operating time, hospital stay, auxiliary procedures, complications (using the Clavien-Dindo grading system), and improvement in the Quality of Life (QoL) score. Differences between proportions [risk difference (RD)]/means [mean difference (MD)] and 95% confidence intervals (CI) were presented. This study is registered at ClinicalTrials.gov: NCT05952635.

FINDINGS: The S-UAS group demonstrated a significantly higher immediately SFR (81.3% versus 49.4%; RD 31.9%; 95% CI 22.5%-41.7%; p = 0.004) compared to the traditional UAS group, as determined by the one-side superiority test. Additionally, the S-UAS group exhibited a higher SFR at 3 months post-operation (87.5% versus 70.0%; RD 17.5%; 95% CI 8.7%-26.3%; p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.